STONY BROOK, NY--(Marketwired - November 15, 2016) - Applied DNA Sciences, Inc. (Applied DNA) (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced today that the U.S. Defense Logistics Agency (DLA) has awarded the company a one-year firm-fixed price Indefinite Delivery Purchase Order (IDPO) contract for FSC 5962 microcircuits. This contract will ensure uninterrupted support of the current DNA program in place since December 2014 at the Product Test Center (PTC) located at the Agency's Land and Maritime facility in Columbus, OH. This long-term contract (LTC) will provide supplies and services for DNA marking, creation of unique SigNature® DNA marks, QC authentication testing, ink and supplies, and training. Also included in support of the effort is the customer facing portal which is the platform that was developed for use by PTC to capture data appropriate to the FSC 5962 commodities. The period of performance is one year with an additional one-year option period.
"We are proud that our DNA program supports DLA in its strategic effort to identify and manage supply system risks," commented Janice Meraglia, Vice President of Government and Military Programs for Applied DNA. "Collaboration with the team at Land and Maritime has allowed for smooth, continuous improvements as we partner on a full forensic solution including people, process and technology."
While the focus of this new contract is on FSC 5962 microcircuits to support existing systems, two additional contracts were completed at the end of July and August 2016. One for the Missile Defense Agency -- Small Business Innovative Research (SBIR) -- and one for the Office of the Secretary of Defense -- Rapid Innovation Fund (RIF). The SBIR allowed for continuation of the effort focused on microcircuits and scale-up of the business model to support volume at the point of manufacture. The RIF expanded upon the DNA program in place for FSC 5962 to establish a single authentication platform for the following six FSGs (as prioritized by DLA):
FSG 59 -- Electrical and Electronic Equipment Components
FSG 31 -- Bearings
FSG 25 -- Vehicular Equipment Components
FSG 29 -- Engine Accessories
FSG 47 -- Pipe, Tubing, Hose, and Fittings
FSG 53 -- Hardware and Abrasives
"Together these contracts have strengthened our core capabilities to offer supply chain solutions across an expanded range of critical commodities," said Dr. James A. Hayward, president and CEO of Applied DNA. "These parts and assemblies are used in defense, industrial and consumer markets," he added.
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016, May 12, 2016 and August 11, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.